Amyloid-beta clearance in Alzheimer's disease
Strong evidence continues to accumulate indicating that amyloid-beta (Aß) is a central part of Alzheimer’s disease (AD) pathogenesis in spite of the negative evidence coming from failed clinical trials. Therefore, mechanisms of clearance of Aß are of great interest in understanding AD pathogenesis a...
Bewaard in:
Gepubliceerd in: | Frontiers Research Topics |
---|---|
Hoofdauteurs: | , |
Formaat: | Livro |
Taal: | Inglês |
Gepubliceerd in: |
Frontiers Media SA
2015
|
Onderwerpen: | |
Online toegang: | https://directory.doabooks.org/handle/20.500.12854/40785 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|